2024 Biomarkers of Aging Conference
The Premier Conference on Biomarkers of Aging
November 1-2 2024
The Joseph B. Martin Conference Center
Harvard Medical School
Boston, Massachusetts, USA
Anti-aging treatments are on the verge of becoming commercially available.
However, there is still a pressing need for standardized, clinically validated tools to accurately measure the aging process and quantitatively evaluate the effects of healthspan- and lifespan-extending interventions in humans. As the field continues to progress and grow, establishing these standards is essential for advancing our understanding and ensuring the success of future innovations.
2024 Speakers & Panelists
Austin Argentieri, PhD
Harvard University
Omar Abudayyeh, PhD
Harvard University
Nir Barzilai, MD
Albert Einstein
College of Medicine
Ed Boyden, PhD
MIT
Andrew Brack, PhD
ARPA-H
Jason Buenrostro, PhD
Harvard University
Luigi Ferrucci, PhD
National Institute of Aging
Eric Morgen, MD
BioAge Labs
David Furman, PhD
Buck Institute
Vadim Gladyshev, PhD
Harvard University
Christin Glorioso,
MD, PhD
NeuroAge Therapeutics
Dane Gobel
Methuselah Foundation
Dave Gobel
Methuselah Foundation
Jonathan Gootenberg, PhD
Harvard University
Sara Hägg, PhD
Karolinska Institutet
Chiara Herzog, PhD
University of Innsbruck
Steve Horvath, PhD
Altos Labs
Jamie Justice, PhD
XPRIZE Healthspan
Gordan Lauc, PhD
University of Zagreb
Xiao-Jun Ma, PhD
Alamar Biosciences
Raymond H. Mak, MD
Harvard University
Andrea Maier, MD, PhD
NUS
Riccardo E. Marioni, PhD
University of Edinburgh
Mahdi Moqri, PhD, MBA
Harvard University
Seth Paulson
Methuselah Foundation
Viviana Perez, PhD
Hevolution Foundation
Jesse Poganik, PhD
Harvard University
Julian Reinhard
Evotec
Björn Schumacher, PhD
University of Cologne
Vittorio Sebastiano, PhD
Stanford University
Raghav Sehgal, PhD
Yale University
David Sinclair, PhD
Harvard University
Michael Snyder, PhD
Stanford University
Alexandra Stolzing, PhD
Loughborough University
Gavin Zhou, PhD
Regen Bio
Waylon Hastings, PhD
Texas A&M
Christian Behrens, PhD, RD
Bayer
John Earls, PhD
Buck Institute
George Church, PhD
Wyss Institute
Jessica Lasky-Su, PhD
Harvard University
Jessica Kasamoto, MSc
Yale University
Alexander Tyshkovskiy, PhD
Harvard University
John Tsang, PhD
Yale University
Tina Woods, MBA
Collider Health
Eric Verdin, MD
Buck Institute
Tony Wyss-Coray, PhD
Stanford University
Kejun Albert Ying, PhD
Harvard University
2024 Conference Schedule
Friday, Nov 1:
Cutting-Edge Academic Science
Talks and Panels with world-leading Academic scientists. Topics include: omics and multi-omics biomarkers, molecular, digital/imaging, and physiological biomarkers, systemic aging and tissue/organ-specific biomarkers, longitudinal biomarkers, validation, and benchmarking
Poster Session and Flash Talks
Catered light breakfast, lunch, and refreshments
Saturday, Nov 2:
Translational, Clinical & Regulatory
Talks and Panels with global Industry leaders. Topics include: longevity biotech and aging biomarkers, biomarker standardization, qualifications, and regulation, biomarkers guided gerotherapeutics, clinical biomarkers and outcomes, role of open innovation, including XPRIZE Healthspan and Biomarkers of Aging Challenge, with presentations by winning teams.
Poster Session and Flash Talks
Catered light breakfast, lunch, and refreshments
2024 Sponsors & Media Partners
Funding for this conference was made possible, in part, by 1R13 AG092128-01 from NIA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Media Partners
Join us to celebrate another year of collaboration and progress towards developing validated biomarkers of aging.
Our inaugural Symposium on December 4th 2023 at the Buck Institute in Novato, California brought together over 300 participants and featured 33 speakers from diverse areas of our community, including representatives from numerous research institutions, regulatory agencies, big pharma, NGOs, clinical practices, and biopharma startups. Check out the 2023 highlights here.